The tritium isotope effect of sn-glycerol 3-phosphate oxidase and the effects of clofenapate and N-(2-benzoyloxyethyl)norfenfluramine on the esterification of glycerol phosphate and dihydroxyacetone phosphate by rat liver mitochondria.
1. Owing to a (3)H isotope effect, the mitochondrial sn-glycerol 3-phosphate oxidase (EC 1.1.99.5) had a mean activity which was 8.4 times less with sn-[2-(3)H]-rather than with sn-[1-(14)C]glycerol 3-phosphate as a substrate. 2. A method for measuring the simultaneous synthesis of lipid from glycerol phosphate and dihydroxyacetone phosphate in rat liver mitochondria is described. 3. The lipid synthesized by rat liver mitochondria from sn-[1-(14)C]glycerol 3-phosphate was mainly phosphatidate and lysophosphatidate, whereas that synthesized from dihydroxy[1-(14)C]acetone phosphate was mainly acyldihydroxyacetone phosphate. 4. Additions of NADPH facilitated the conversion of acyldihydroxyacetone phosphate into lysophosphatidate and phosphatidate. 5. Hydrazine (1.4mm) or KCN (1.4mm) inhibited the synthesis of lipids from dihydroxyacetone phosphate but not from glycerol phosphate. 6. Clofenapate (1-2.5mm) inhibited the synthesis of lipids from dihydroxyacetone phosphate but slightly stimulated synthesis from glycerol phosphate. 7. The methanesulphonate of N-(2-benzoyloxyethyl)norfenfluramine, at 0.25-0.75mm, inhibited lipid synthesis from both glycerol phosphate and dihydroxyacetone phosphate.
D000096:Acetone / Q000378:metabolism*; D000818:Animals; D001565:Benzoates / Q000494:pharmacology; D001713:Biphenyl Compounds / Q000494:pharmacology*; D002087:Butyrates / Q000494:pharmacology*; D002250:Carbon Radioisotopes; D003486:Cyanides / Q000494:pharmacology; D004987:Ethers / Q000494:pharmacology; D005277:Fenfluramine / Q000494:pharmacology*; D005993:Glycerolphosphate Dehydrogenase / Q000378:metabolism*; D005994:Glycerophosphates / Q000378:metabolism; D006834:Hydrazines / Q000494:pharmacology; D066298:In Vitro Techniques; D007700:Kinetics; D050356:Lipid Metabolism; D008930:Mitochondria, Liver / Q000378:metabolism*; D009249:NADP / Q000494:pharmacology; D009943:Organophosphorus Compounds / Q000378:metabolism; D051381:Rats; D013997:Time Factors; D014306:Trioses / Q000378:metabolism*; D014316:Tritium / Q000494:pharmacology*
D001565:Benzoates; D001713:Biphenyl Compounds; D002087:Butyrates; D002250:Carbon Radioisotopes; D003486:Cyanides; D004987:Ethers; D005994:Glycerophosphates; D006834:Hydrazines; D009943:Organophosphorus Compounds; D014306:Trioses; D014316:Tritium; D000096:Acetone; D005277:Fenfluramine; D009249:NADP; D005993:Glycerolphosphate Dehydrogenase